Catalyst Pharmaceuticals (United States)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Medicine 4.4×
• Neuroscience 4.4×
• Biochemistry, Genetics and Molecular Biology 1.5×

By volume in 2022–2025: Autoimmune Neurological Disorders and Treatments, Myasthenia Gravis and Thymoma, Amyotrophic Lateral Sclerosis Research and Hereditary Neurological Disorders.

1. 1 Autoimmune Neurological Disorders and Treatments Neurology 1 works
2. 2 Myasthenia Gravis and Thymoma Neurology 0 works
3. 3 Amyotrophic Lateral Sclerosis Research Neurology 0 works
4. 4 Hereditary Neurological Disorders Cellular and Molecular Neuroscience 0 works
5. 5 Pain Mechanisms and Treatments Physiology 0 works
6. 6 Salivary Gland Tumors Diagnosis and Treatment Surgery 0 works
7. 7 Peripheral Neuropathies and Disorders Neurology 0 works
8. 8 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 0 works
9. 9 Eicosanoids and Hypertension Pharmacology Biochemistry 0 works
10. 10 Inflammatory mediators and NSAID effects Pharmacology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 82% higher than in 2013–2017.

• University of Miami
• Dr. John T. Macdonald Foundation
• American Orchid Society
• Clinical Research of South Florida
• Montgomery Botanical Center
• Alpha-1 Foundation
• Florida Academic Dermatology Center
• Global Health Association of Miami